We are delighted that we have been granted a license to deliver Medtech Early Technical Assessments (META) on behalf of National Institute for Health and Care Excellent (NICE).
The META tool is an affordable platform developed by NICE to help MedTech innovators understand what evidence is needed to make a convincing case to payers and commissioners for their technology. JB Medical is now licensed to support innovators to use the tool to identify ways to optimise their technology development plans, and to identify potential next steps for bringing their technology to market.
If you are a MedTech innovator wishing to understand how your R&D plans could be optimised, how strong your technology’s clinical and cost-effectiveness evidence bases are, or how your route to market could be accelerated, get in touch with JB Medical’s META facilitator Dr Melissa Kapoor (email
JB Medical offers three levels of META service: Basic, Standard and Full. This means there is a service available for every budget and every stage of a technology’s stage of development.
We are experts in MedTech market access, having supported more than 300 MedTech companies with a wide range of market access services, including health economics (including pricing and building sales tools), clinical trial design and evaluation, systematic literature review and NICE MTEP and HTA preparation.